American Heart Journal

Article	Citations
Association of Increased Fructose Consumption with Atrial Fibrillation Symptoms	210
Differences in Clinical Outcomes Between Non-Obese Caucasian and African American Populations Who Have Diabetes, A Nation-Wide Study	187
Table of Contents	100
Table of Contents	91
Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial	88
Rationale and design of NUDGE-CKD: A nationwide randomized factorial trial of electronic nudges for increasing guideline-directed medical therapy in chronic kidney disease	73
Editorial Board	66
Possibilities of Screening and Intervention Strategies in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus with the Risk of HF	66
Arrhythmia Risk in Non-Obese versus Obese Patients with Psoriatic Arthritis and Type 2 Diabetes	57
Impact of NT-proBNP Levels on Clinical Outcomes in Peripartum Cardiomyopathy: A Propensity-Matched Analysis Using the TriNetX Research Network	54
Tirzepatide vs Semaglutide in Coronary Artery Disease and Obesity: Real-World Cardiovascular Outcomes Analysis from the TriNetX Research Network	43
Information for Readers	40
The trial to assess chelation therapy 2 (TACT2): Rationale and design	38
Accuracy of Diagnosing Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and DKA-HHS: The Significance for Cardiac Function	38
Information for Readers	37
Heart failure and nocturnal hypoxemic burden, the connection is getting closer and closer	35
Absence of coronary artery disease in patients undergoing coronary imaging and association with amyloidosis: A Danish nationwide study	35
Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER	34
Diagnostic performance of a novel automated CT-derived FFR technology in detecting hemodynamically significant coronary artery stenoses: A multicenter trial in China	33
Non-Adherence to Antihypertensive Medications Among the US Population: A Pooled Analysis of 22 Million Patients	32
Nationwide Utilization of Danish Government Electronic letter system for increasing inFLUenza vaccine uptake (NUDGE-FLU): Study protocol for a nationwide randomized implementation trial	30
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial	30
COMPARE LAAO: Rationale and design of the randomized controlled trial “COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at hig	30
Cardiac auscultation skills among medical trainees	30
Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded e	29

The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism	29
Risk of delayed percutaneous coronary intervention for STEMI in the Southeast United States	28
Democracy, healthcare, and the public good	26
Differences in incident and recurrent myocardial infarction among White and Black individuals aged 35 to 84: Findings from the ARIC community surveillance study	26
Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings	26
Accuracy of instantaneous wave-free ratio and fractional flow reserve derived from single coronary angiographic projections	26
Table of Contents	25
Cardiovascular Outcomes in Type 2 Diabetes Patients with Inflammatory Polyarthropathy: SGLT2 Inhibitors versus GLP-1 Receptor Agonists	25
Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial	25
Ambulatory inotropic therapy: To what end?	25
Physician responses to apple watch-detected irregular rhythm alerts	25
Rheumatoid Arthritis and the Connection with Cardiovascular Disease Mortality	25
Information for Readers	25
Evaluation of Huawei smart wearables for detection of atrial fibrillation in patients following ischemic stroke: The Liverpool-Huawei stroke study	25
Lipoprotein(a) immunoassays and their associations with coronary artery calcification and aortic valve calcification	24
Obicetrapib Does Not Accumulate in Adipose Tissue: Results from Studies in Man and Non-Human Primates	24
Single Nucleotide Variants of the MCM6 Gene as a Risk Factor for Metabolically Unhealthy Obesity in Children	24
Clinical Data and Diagnostic findings in Patients with Ischemic Heart Disease undergoing Coronary Angiography: a Cross-sectional study from a Tertiary Hospital in Sudan, Africa	24
A Bayesian re-analysis of the STRESS trial	23
Enhancing risk stratification for incident systolic heart failure through machine learning and natural language processing	23
The incremental role of late gadolinium enhancement in risk stratifying high risk patients with hypertrophic cardiomyopathy	22
Diagnostic and prognostic impact of new pathophysiology-based categorization of type 1 and type 2 myocardial infarction: data from the French RICO survey	22
Rationale and design of the Dynamic Coronary Roadmap for Contrast Reduction (DCR4Contrast) in PCI randomized controlled trial	22
Differences in guideline directed medical therapy for rural and non-rural Veterans with heart failure with reduced ejection fraction	21
Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial	21
Diversity of electrocardiographic patterns in left main culprit acute ST-elevation myocardial infarction	21
Relationship between left atrial stiffness, pulmonary congestion, and impaired aerobic capacity in adults with repaired coarctation of aorta	21
Catheter-based left atrial appendage CLOSURE in patients with atrial fibrillation at high risk of stroke and bleeding as compared to best medical therapy: Rationale and design of the prospective rando	20
Validity of international classification of diseases, tenth revision codes in diagnosing myocardial infarction subtypes	20
Chest pain and coronary artery disease in cardiac amyloidosis: Prevalence, mechanisms, and clinical implications	20
Design and rational of the The PRACTICAL-HERO trial: a randomized trial of higher and lower doses of heparin vs placebo for elective diagnostic coronary angiography	19
Longer term benefits of exercise and escitalopram in the treatment of anxiety in patients with coronary heart disease: Six month follow-up of the UNWIND randomized clinical trial	19
Impact of moderate or severe mitral and tricuspid valves regurgitation after transcatheter aortic valve replacement	19
Prehospital treatment with zalunfiban (RUC-4) in patients with ST‐ elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial	19
Edoxaban-based long-term antithrombotic therapy in patients with atrial fibrillation and stable coronary disease: Rationale and design of the randomized EPIC-CAD trial	19
Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis	19
Implementing remote patient monitoring to improve hypertension control in a primary care network: Rationale and design of the monitor-BP Cluster Randomized Trial	19
Prospective randomized comparison between upgraded ‘2C3L’ vs. PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial design	18
Design and rationale of CATO, a Phase IIA, randomized, double-blind, placebo-controlled study of single or repeated intravenous administration of umbilical cord-derived mesenchymal stromal cells in is	18
Premorbid physical activity and prognosis after incident myocardial infarction: The atherosclerosis risk in communities study	18
Implementing guideline-directed medical therapy: Stakeholder-identified barriers and facilitators	18
The pediatric heart network's study on long-term outcomes of children with HLHS and the impact of Norwood Shunt type in the single ventricle reconstruction trial cohort (SVRIII): Design and adaptation	18
Adipose tissue n-3/n-6 fatty acids ratios versus n-3 fatty acids fractions as predictors of myocardial infarction	18
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinica	17
Editorial Board	17
Editorial Board	17
Pursuing functional biomarkers in complex disease: Focus on pulmonary arterial hypertension	17
Encouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: Rationale and design of a randomized controlled trial	17
GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: Cardiovascular Outcomes and Mortality Benefits	17
Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry	17

Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome	17
Efficacy of Liraglutide Versus Gliclazide in Treatment of Patients with Type II Diabetes Mellitus: Systematic Review and Meta-Analysis	17
Predicting short-term outcomes after transcatheter aortic valve replacement for aortic stenosis	16
Development of a unified national database of primary percutaneous coronary intervention centers with co-located emergency departments, 2020	16
Gamification-augmented home-based exercise for peripheral artery disease: Rationale and design of the GAMEPAD Study	16
ISCHEMIA-EXTEND studies: Rationale and design	16
Results from a Randomized, Open-Label, Crossover Study Evaluating Pharmacokinetic Interaction Between the Aldosterone Synthase Inhibitor Baxdrostat and Metformin in Healthy Human Subjects	16
The effects of low-dose colchicine on the progression of aortic valve stenosis: Rationale, design, and baseline characteristics of the Colchicine and Inflammation in Aortic Stenosis (CHIANTI) trial	16
Perioperative bleeding and outcomes after noncardiac surgery	16
Prognostic impact of quantitative flow ratio (QFR)-consistent complete revascularization in patients with myocardial infarction and multivessel coronary artery disease	16
Corrigendum to ``Transcoronary cooling and dilution for cardioprotection during revascularisation for ST-segment elevation myocardial infarction: design and rationale of the STEMI-Cool study''. [Am He	16
Neonatal outcomes of pregnancy in women with congenital heart disease	16
Inflammation biomarkers and incident coronary heart disease: the Reasons for Geographic And Racial Differences in Stroke Study	16
Trends in outcomes and resource utilization for acute myocardial infarction admissions during the COVID-19 pandemic	16
Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria	16
Impact of a clinical atrial fibrillation risk estimation tool on cardiac rhythm monitor utilization following acute ischemic stroke: A prepost clinical trial	15
Prediabetes in Takotsubo Syndrome: Impact on Cardiovascular Outcomes and Mortality in a Propensity-Matched Cohort Study	15
Benefits of Fiber-Rich Snacks on Waist Circumference and Atergenic Index of Plasma in Obese	15
Effect of colchicine on progression of known coronary atherosclerosis in patients with STable CoROnary artery disease CoMpared to placebo (EKSTROM) trial—rationale and design	15
Clinical Outcomes in Non-Obese Caucasian and Hispanic Populations with DM, a Nation-Wide Study	15
Deploying a novel custom mobile application for STEMI activation and transfer in a large healthcare system to improve cross-team workflow. STEMIcathAID implementation project	15
Information for Readers	15
Editorial Board	15
Information for Readers	15
Familial Hypercholesterolemia and Type 2 Diabetes: Diagnostic and Therapeutic Challenges	14
Estimate Patient's 10-Years Cardiovascular Risk using Arteriosclerotic Cardiovascular Disease Tool a Cross-Sectional Study in Al-Harja, Asser, Saudi Arabia, 2021	14
Pragmatic trial of messaging to providers about treatment of acute heart failure: The PROMPT-AHF trial	14
Patient characteristics, treatment patterns, and prognosis in drug-use-associated infective endocarditis in Denmark from 1999 to 2018	14
Influence of left ventricular ejection fraction in patients undergoing contemporary pLVAD-supported high-risk PCI	14
The Role of Dialysis in Outcomes of LVAD Implantation in Chronic Kidney Disease Patients: Insights from US National Readmission Database	14
Prognostic value of echocardiography for heart failure and death in adults with chronic kidney disease	14
Transcatheter aortic‐valve implantation with or without on‐site cardiac surgery: The TRACS trial	13
Rationale and design of the direct oral anticoagulants for prevention of left ventricular thrombus after anterior acute myocardial infarction (APERITIF) trial	13
Mortality and rehospitalization after mitral valve surgery as a function of age and key comorbidities	13
Complete revascularization in patients with acute myocardial infarction and multivessel disease: Pooled analysis of Kaplan-Meier-derived individual-patient-data	13
Advancement of the implementation of evidence-based therapies for cardiovascular-kidney-metabolic conditions: A multi-stakeholder perspective	13
Design and rationale of a pragmatic randomized clinical trial of early dronedarone versus usual care to change and improve outcomes in persons with first-detected atrial fibrillation – the CHANGE AFIB	13
Early oral anticoagulation monotherapy after PCI: Insights from the POEM trial	13
Plasma proteomics for prediction of subclinical coronary artery calcifications in primary prevention	13
Rationale and design of the early valve replacement in severe asymptomatic aortic stenosis trial	13
Surrogate markers of gut dysfunction are related to heart failure severity and outcome–from the BIOSTAT-CHF consortium	13
Framework of the strengths and challenges of clinically integrated trials: An expert panel report	13
Prognostic Value of Triglyceride-Glucose Index for the Prediction of Cardiovascular Events: Results from the Multi-Ethnic Study of Atherosclerosis (MESA)	12
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure	12
Editorial Board	12
Towards a person-centered after-visit summary to facilitate improved heart failure care (HF-AVS): A scoping review and call to action	12
Editorial Board	12
Accurate Fick cardiac output estimation: direct and simultaneous oxygen consumption measurement is imperative in heart failure	12
Association Between Hospital Ownership Type and ST-Segment Elevation Myocardial Infarction Outcomes: Insights from the National Readmission Database, 2016-2022	12
Anatomic and physiologic classification of adults with congenital heart disease to predict adverse outcomes: Use of administrative codes compared to clinical staging	12
Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease – Design and rationale of the randomized COMPLETE-NSTEMI trial	12
Dyslipidaemia Patterns and Risk Factors Among Patients with Diabetes, Hypertension, and Both Diabetes and Hypertension at a Tertiary Hospital in Malawi	12
Extra-virgin olive oil and additional cardiovascular outcomes in the PREDIMED Trial: An outcome-wide perspective	12
Patterns of diuretic titration during inpatient management of acute decompensated heart failure	12
Sex-differences in 5 year Survival with Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Graft surgery in patients with Diabetes and Multivessel Disease	12
Direct oral anticoagulation interruption versus continuation in patients undergoing elective invasive coronary angiography or percutaneous coronary intervention: design and rationale of the South Limb	12
Rationale and design of European microcirculatory resistance and absolute flow team: The Euro-CRAFT registry	12
Potassium-competitive acid blocker vs proton-pump inhibitor in patients receiving antithrombotic therapy who are at high risk for gastrointestinal bleeding: Rationale and design of the randomized PROT	12
Editorial Board	12
Distinct triglyceride-glucose trajectories are associated with different risks of incident cardiovascular disease in normal-weight adults	12
Bempedoic Acid for Management of Dyslipidemia from an Indian Perspective: An Expert Consensus Report	12
Association of change in QRS duration with chronic heart failure outcomes	12
Tailored hydration for the prevention of contrast-induced acute kidney injury after coronary angiogram or PCI: A systematic review and meta-analysis	12
Strategy to optimize PeriproCeduraL AnticOagulation in structural transseptal interventions: Design and rationale of the STOP CLOT trial	12
Trends in urine drug screening and positivity among patients with heart failure: Insights from a large health system	12
Physician assessment of aortic stenosis severity, quantitative parameters, and long-term outcomes: Results from the KP-VALVE project	12
Danish-German cardiogenic shock trial—DanGer shock: Trial design update	12
Association between visit frequency, continuity of care, and pharmacy fill adherence in heart failure patients	12
Rate versus rhythm control in patients with newly diagnosed atrial fibrillation: Effects of the treatment timing on health status outcomes	11
Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries	11
Self-Medication Practices from the Perspective of Tunisian Cardiovascular Patients – A Community Pharmacy-Based Survey	11
Editorial Board	11
Precision Profiling of Advanced CVD and CKM Syndrome Through Lipidomics and Immunophenotyping	11
OCEAN trial update	11
Table of Contents	11
Relationship Between Vaccines Against Coronavirus Disease 2019 (Covid-19) and Myocarditis	11
Table of Contents	11
Cardiovascular Risk in Obstructive Sleep Apnea: Impact of Glycemic Control in Diabetes — Insights from the TriNetX Network	11
Rationale for and design of a multicenter, placebo-controlled, phase 3 study to assess efficacy and safety of intranasal etripamil for the conversion of paroxysmal supraventricular tachycardia	11
Use of e-cigarettes, traditional combustible cigarettes, and high sensitivity C-reactive protein: The Cross Cohort Collaboration	11

Association of testosterone-induced increase in neutrophil and monocyte counts with thromboembolic events: The TRAVERSE trial	11
The Effect of Avocado Drink (Persea Americana Mill) on the Incidence of Ballooning Hepatocyte in the Liver Organs of Rats (Rattus Novergicus) Induced by Hypercholesterolemia	11
Information for Readers	11
Proportion of Obesity-Related Conditions Attributable to Obesity in US Adolescents and Young Adults	11
Risk Scale for Patients with Newly Diagnosed Diabetic Foot Ulcer - Which Patients May Experience Healing Failure or Need Revascularization	11
Single Nucleotide Variants of the VDR Gene and Cardiometabolic Risk in Obesity	11
Design and rationale of a randomized clinical trial assessing the effect of inclisiran on atherosclerotic plaque in individuals without previous cardiovascular event and without flow- limiting lesions	10
Enhancing cardiac rehabilitation adherence through home-based rehabilitation and behavioral nudges: The ERA nudge study design and rationale	10
Mavacamten in symptomatic adolescent patients with obstructive hypertrophic cardiomyopathy: design of the phase 3 SCOUT-HCM trial	10
Effect of tirzepatide on the progression of coronary atherosclerosis using MDCT: Rationale and design of the tirzepatide treatment on coronary atherosclerosis progression: The (T-Plaque) randomized-co	10
Design and rationale of the HD PCI trial: A cluster randomized crossover trial of higher vs. lower dose heparin for elective percutaneous coronary intervention	10
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet	10
Table of Contents	10
Study protocol and baseline characteristics of Randomized trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid: RESPECT-EPA, the combination of	10
Randomized controlled trial of urinE chemiStry guided aCute heArt faiLure treATmEnt (ESCALATE): Rationale and design	10
The effect of tablet computer-based telemonitoring added to an established telephone disease management program on heart failure hospitalizations: The Specialized Primary and Networked Care in Heart F	10
Editorial Board	10
A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) – design and rationale of the left ventricular unloading trial domain	10
Race, hypertensive disorders of pregnancy and outcomes in peripartum cardiomyopathy	10
Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial	10
Investigating the Smoker's Paradox: Aortic Stenosis Patient Outcomes in Smokers	10
On-treatment blood pressure and cardiovascular mortality in adults with repaired coarctation of aorta	10
Overview of 2024 FDA Advisory Panel Meeting on the TriClip transcatheter tricuspid valve repair system	10
Does targeted positioning of the left ventricular pacing lead towards the latest local electrical activation in cardiac resynchronization therapy reduce the incidence of death or hospitalization for h	10
Lactate Dehydrogenase can be Considered a Predictive Marker of Severity and Mortality of Covid-19 in Diabetic and Non-Diabetic Patients. A Case Series	10
Transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis aged 70 years or younger: A NOTION-2 substudy	10
Transcatheter edge-to-edge repair for chronic functional mitral regurgitation in patients with very severe left ventricular dysfunction	10
Meta‐analysis assessing the sensitivity and specificity of 18F‐FDG PET/CT for the diagnosis of prosthetic valve endocarditis (PVE) using individual patient data (IPD)	10
Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE)	10
Obicetrapib Alone and in Combination with Ezetimibe Reduces Atherosclerotic Lesion Prevalence, Size and Severity in ApoE*3-Leiden.CETP Mice	9
Central Venous Access: Conventional Seldinger Versus Ultrasound-Guided Technique to Reduce Associated Complications in A School Hospital	9
Table of Contents	9
Quality and rapidity of anticoagulation in patients with acute pulmonary embolism undergoing mechanical thrombectomy	9
Prevalence and clinical correlates and characteristics of “Super Fontan”	9
Rationale and design of the multicentric randomized EVAOLD trial: Evaluation of a strategy guided by imaging versus routine invasive strategy in elderly patients with ischemia	9
Table of Contents	9
Incorporating Ensembled Stacked Approach into Automated Machine Learning in an Attempt to Predict Acute Ischemic Heart Disease in Patients with Atypical Chest Pain: Secondary Analysis of a Single-Cent	9
Prognosis of patients with nonspecific electrocardiogram findings in a Tanzanian emergency department	9
Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension – the SaltSwitch Online Grocery Shopping randomized trial	9
The prognostic significance of single-lead ST-segment resolution in ST-segment elevation myocardial infarction patients treated with primary PCI – A substudy of the randomized TOTAL trial	9
Adiponectin as a Biomarker for Subclinical Atherosclerosis in Obese Adults with Type 2 Diabetes Mellitus	9
Editorial Board	9
Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health study	9
Predictors of Major Adverse Limb Events After Infrainguinal Bypass in Patients with Diabetes	9
Editorial Board	9
The contemporary cardio-obstetrics team: The path to improving maternal outcomes in high-risk patients	9
Design, rationale, and characterization of the mobile health based occupational cardiovascular risk intervention study (mHealth-OPEN study)	9
Hidden in Plain Sight: The Association of Cystic Fibrosis and Diabetic Ketoacidosis- A Nationwide Study	9
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation	8
Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial	8
Pregnancy in women with congenital heart disease: New insights into neonatal risk prediction	8
The Use of Extracorporeal Membrane Oxygenation (ECMO) and Protective Mechanical Ventilation in the Treatment of Acute Respiratory Failure	8
Prediction of early death after atrial fibrillation diagnosis using a machine learning approach: A French nationwide cohort study	8
Computerized clinical decision support to improve stroke prevention therapy in primary care management of atrial fibrillation: a cluster randomized trial	8
Rationale and design for the study of recombinant human hepatocyte growth factor plasmid in the treatment of patients with chronic limb-threatening ischemia (HOPE CLTI): Randomized, placebo-controlled	8
Caribbean and South American team-based strategy to control hypertension (CATCH): Rationale and study design of a cluster randomized trial	8
at onal anish endocarditis st die – Design and objectives of the NIDUS registry	8
Pulsed field ablation-related hemoglobinuria and acute kidney injury: Insights and strategies for effective management	8
Burden of cardiometabolic risk factors and vascular health	8
Contemporary laboratory assessment of acute cardiorenal syndrome for early diagnosis: A call for action	8
The pathophysiology of patent foramen ovale and its related complications	8
Comparing the outcomes of rheumatic heart disease in pregnancy complicated with and without atrial fibrillation: A propensity score matched analysis	8
Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2)	8
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trials	8
The randomized controlled trial to compare temporary permanent pacemaker vs temporary pacemaker in patients with conduction block after transcatheter aortic valve replacement: Rationale and design of	8
Comparative Cardiovascular Outcomes Between Carvedilol and Metoprolol in Patients with Takotsubo Syndrome: A Propensity-Matched Cohort Study	8
Association Between Glycemic Control and Adverse Outcomes in Atrial Fibrillation: Evidence from a Large Real-World Cohort	8
Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry	8
Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics	8
Baseline NT-proBNP nonresponse score and health status measures in assessing treatment responses in heart failure with reduced ejection fraction	8
Incremental cost of complications after TAVR and SAVR in contemporary clinical practice	8
Biomarkers in Determining the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Hypertension	8
Physicians' perspectives on percutaneous left atrial appendage occlusion for patients with atrial fibrillation	8
Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease	8
Effect of opt-in versus opt-out framing on trial recruitment: a study within a trial of the GAMEPAD randomized trial	8
Medicare coverage gap status, adherence to oral anticoagulation, and stroke rates in patients with atrial fibrillation	8
Information for Readers	8
Prognosis of Hospitalizations of Patients with Different Phenotypes of Heart Failure in Type 2 Diabetes Mellitus	8
Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial	8
The coronary microvascular angina cardiovascular magnetic resonance imaging trial: Rationale and design	8
Information for Readers	8
The ENHANCE-AF clinical trial to evaluate an atrial fibrillation shared decision-making pathway: Rationale and study design	8
Association of sex with in-hospital management and outcomes of patients with heart failure: Data from the REAL-HF registry	8
Short-term outcomes of ticagrelor monotherapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction; a randomized pilot study	8
External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular disease	7
Microalbuminuria in Patients with Type 2 Diabetes Mellitus Treated with a Phytoformula as Adjuvant.	7
A randomized trial of antithrombotic therapy in patients with acute coronary syndrome and coronary ectasia	7
Antiplatelet regimens following carotid artery revascularization	7
Zofenopril Treatment Efficacy on Survival, Endostatin and Insulin-Like Growth Factor-1 in Patients with Diabetes Mellitus Type 2 After Acute Myocardial Infarction	7
Rationale and design of the TUXEDO-2 India study: Ultra-Thin strUt Supraflex Cruz versus XiencE in a Diabetic pOpulation with multi-vessel disease–2	7
Anatomical, physiological and inflammatory characterization of nonculprit vessels in patients undergoing primary PCI for ST-elevation myocardial infarction in the presence of multivessel disease: Rati	7
Prognosis of elderly non-valvular atrial fibrillation patients stratified by B-type natriuretic peptide: ELDERCARE-AF subanalysis	7
Telomere, Telomerase and The Aging Heart	7
Center-level factors associated with shorter length of stay following stage 1 palliation: An analysis of the national pediatric cardiology quality improvement collaborative registry	7
Balance of benefit and risk of ticagrelor in patients with diabetes and stable coronary artery disease according to bleeding risk assessment with the CRUSADE score: Data from THEMIS and THEMIS PCI	7